It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The selection of genes that are important for obtaining gene expression data is challenging. Here, we developed a deep learning-based feature selection method suitable for gene selection. Our novel deep learning model includes an additional feature-selection layer. After model training, the units in this layer with high weights correspond to the genes that worked effectively in the processing of the networks. Cancer tissue samples and adjacent normal pancreatic tissue samples were collected from 13 patients with pancreatic ductal adenocarcinoma during surgery and subsequently frozen. After processing, gene expression data were extracted from the specimens using RNA sequencing. Task 1 for the model training was to discriminate between cancerous and normal pancreatic tissue in six patients. Task 2 was to discriminate between patients with pancreatic cancer (n = 13) who survived for more than one year after surgery. The most frequently selected genes were ACACB, ADAMTS6, NCAM1, and CADPS in Task 1, and CD1D, PLA2G16, DACH1, and SOWAHA in Task 2. According to The Cancer Genome Atlas dataset, these genes are all prognostic factors for pancreatic cancer. Thus, the feasibility of using our deep learning-based method for the selection of genes associated with pancreatic cancer development and prognosis was confirmed.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Chiba University, Graduate School of Engineering, Chiba-shi, Japan (GRID:grid.136304.3) (ISNI:0000 0004 0370 1101)
2 Chiba University, Department of Diagnostic Radiology and Radiation Oncology, Graduate School of Medicine, Chiba-shi, Japan (GRID:grid.136304.3) (ISNI:0000 0004 0370 1101)
3 Chiba Cancer Center, Division of Gastroenterological Surgery, Chiba, Japan (GRID:grid.418490.0) (ISNI:0000 0004 1764 921X)
4 Chiba Cancer Center, Division of Hepato-Biliary-Pancreatic Surgery, Chiba-shi, Japan (GRID:grid.418490.0) (ISNI:0000 0004 1764 921X)
5 CyberAgent, Inc., Media Data Tech Studio, Chiyoda-ku, Japan (GRID:grid.459439.6)